Donepezil Therapy and Changes of Symptoms and Glucose Metabolism in Patients With Dementia With Lewy Bodies (DLB)

Trial Profile

Donepezil Therapy and Changes of Symptoms and Glucose Metabolism in Patients With Dementia With Lewy Bodies (DLB)

Completed
Phase of Trial: Phase II

Latest Information Update: 20 Oct 2015

At a glance

  • Drugs Donepezil (Primary)
  • Indications Lewy body disease
  • Focus Therapeutic Use
  • Most Recent Events

    • 14 Oct 2015 Status changed from recruiting to completed, according to ClinicalTrials.gov record.
    • 16 Oct 2014 Planned End Date changed from 1 Aug 2014 to 1 Feb 2015 as reported by ClinicalTrials.gov.
    • 16 Oct 2014 Planned primary completion date changed from 1 Aug 2014 to 1 Feb 2015 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top